An aldose reductase inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

WJ-39

Item No. 46467

Technical Information
Formal Name
3-[(2,3-dichlorophenyl)methyl]-6-methoxy-4-oxo-1(4H)-quinolineacetic acid, monopotassium salt
CAS Number
3009908-95-3
Molecular Formula
C19H14Cl2NO4 • K
Formula Weight
Purity
≥98%
A solid
SMILES
O=C(CN1C=C(CC2=C(Cl)C(Cl)=CC=C2)C(C3=CC(OC)=CC=C31)=O)[O-].[K+]
InChi Code
InChI=1S/C19H15Cl2NO4.K/c1-26-13-5-6-16-14(8-13)19(25)12(9-22(16)10-17(23)24)7-11-3-2-4-15(20)18(11)21;/h2-6,8-9H,7,10H2,1H3,(H,23,24);/q;+1/p-1
InChi Key
KOVHOMQLMHEHRB-UHFFFAOYSA-M
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    WJ-39 is an inhibitor of aldose reductase.1,2 It reduces high glucose-induced increases in mitochondrial reactive oxygen species (ROS) production and apoptosis in HK-2 kidney epithelial cells.2 WJ-39 (20-40 mg/kg) reduces renal aldose reductase activity, increases renal mitophagy, and rescues renal tubule morphology in a rat model of diabetic nephropathy induced by streptozotocin (Item No. 13104) and a high-fat diet.1,2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zhou, X., Liu, Z., Ying, K., et al. WJ-39, an aldose reductase inhibitor, ameliorates renal lesions in diabetic nephropathy by activating Nrf2 signaling. Oxid. Med. Cell. Longev. 7950457 (2020).

    2. Yang, L., Xu, L., Hao, X., et al. An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling. Eur. J. Pharmacol. 967, 176376 (2024).